✦ LIBER ✦

An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development

✍ Scribed by Christopher Viereck; Pol Boudes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical reality of guidelines for p

✍ O. Vaccaro; M. Boemi; F. Cavalot; P. De Feo; R. Miccoli; L. Patti; A.A. Rivelles 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 368 KB

Impact of biomarkers for endothelial dys

✍ A. Natarajan; S. M. Marshall; P. J. Kesteven; J. M. McComb; M. K. Rutter 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

An analysis of the relative risk for hyp

✍ Díez, J. J.; Iglesias, P. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

The Clinical Implications of the CHICAGO

✍ Tamar Polonsky; Theodore Mazzone; Michael Davidson 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Multivariate analysis of risk factors fo

✍ Yasuji Arase; Fumitaka Suzuki; Kenji Ikeda; Hiromitsu Kumada; Hiroshi Tsuji; Tet 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 246 KB

The Impact of Training Modalities on the

✍ Dominique Hansen, Paul Dendale, Luc J. C. van Loon… 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 202 KB